View New Articles By
Adenoid cystic carcinoma (ACC) is a rare but aggressive cancer that usually develops in the salivary glands and is often diagnosed in younger adults. Because of its rarity, ACC has received relatively little attention from cancer researchers, and as a result, there are no approved therapies for the disease.
The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. This prestigious Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding to investigate cancer causes, mechanisms, therapies, and prevention.
Craniopharyngiomas are a rare type of brain tumor that arise near the pituitary gland and are very difficult to treat, whether surgically or with radiation therapy, without inflicting vision loss, memory loss, or hormone disruption. Even in cases when the tumor is successfully removed, craniopharyngiomas are notorious for coming back.
The Damon Runyon Cancer Research Foundation has named six new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation's leading scientists and clinicians.
If you asked a hundred people to rate a hundred movies, you would generate enough data to be able to make some predictions. Someone who enjoyed Notting Hill would likely enjoy Pretty Woman, for instance; the new Guardians of the Galaxy movie will likely be a hit with longtime Marvel fans. This is an example of a bipartite dataset, which measures interactions between two types of entries—in this case, movies and viewers—and can be used not only to predict unmeasured interactions but also to reveal the underlying rules governing a system.
The Damon Runyon Cancer Research Foundation is pleased to announce that it will increase its Fellowship stipend by 15% over the award’s four-year term. Under the new terms, the Fellowship stipend will start at $70,000 and increase by $2,000 each year. Fellows will continue to receive an additional $2,000 each year for research-related expenses, for a total of $300,000 over the four years.
The National Academy of Sciences (NAS), established in 1863, is the body of distinguished researchers “charged with providing independent, objective advice to the nation on matters related to science and technology.” Election to membership is among the highest honors a scientist can receive. This year, three Damon Runyon alumnae joined the NAS ranks, bringing the total number of Damon Runyon alumni in NAS to 100.
At the annual meeting of the American Association for Cancer Research, held this spring in Orlando, former Damon Runyon Clinical Investigator John V. Heymach, MD, PhD, started with the bad news.
It is with shock and profound sadness that we announce the passing of Damon Runyon Board Member Meghan Raveis on Friday, June 23. She was hit by a car while walking near her home in Fairfield, Connecticut. We send our deepest condolences to Meghan’s husband and their three children, as well as to the entire Raveis family.
The Damon Runyon Cancer Research Foundation held its Annual Breakfast at Cipriani 42nd Street in New York on Wednesday, June 7, 2023. The event raised over $1 million to support promising early-career scientists pursuing innovative strategies to prevent, diagnose, and treat all forms of cancer.
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
